Edwards Lifesciences is down -28.3%, or -$24.64 to $62.31.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EW:
- Edwards Lifesciences Bolsters Cardiac Care with Key Acquisitions
- EW Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Edwards Lifesciences price target raised to $110 from $105 at Truist
- Edwards Lifesciences Expands with Innovalve Acquisition Deal
- Edwards Lifesciences acquires early-stage TMVR company Innovalve, no terms